Adejumo Samson A, Oli Angus Nnamdi, Okoye Ebere Innocent, Nwakile Calistus Dozie, Ojiako Chioma Miracle, Okezie Ugochukwu Moses, Okeke Ifeanyi Justin, Ofomata Chijioke M, Attama Anthony A, Okoyeh Jude N, Esimone Charles Okechukwu
Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nigeria.
Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Federal University Oye Ekiti, Ekiti State, Nigeria.
Adv Pharm Bull. 2021 May;11(3):543-556. doi: 10.34172/apb.2021.063. Epub 2020 Oct 20.
Biosurfactants are applied in drug formulations to improve drug solubility and in some cases, treat diseases. This study is focused on generating, extracting, purifying and then characterizing biosurfactants from bacterial isolates of palm oil wastes and abattoir soil origins. Eight bacteria were isolated from the soil and sludge samples, out of which four (50%) were found to produce biosurfactants. (37.5%) and (50%) were isolated and identified from these samples using mineral salt medium, nutrient agar and Cetrimide agar. Mutant isolates of BS3 and PS2 were used to produce biosurfactants using mineral salt medium as enrichment medium and extraction was done using membrane filter. The mutant strains BS3 and PS2 generated biosurfactants that displayed significant solubility and dissolution properties by enhancing the percentage solubility of piroxicam to 62.86 and 54.29% respectively, and achieved 51.71 and 48.71% dissolution of the drug in 0.1N HCl. From the results obtained, the produced biosurfactants could serve as a better alternative to conventional surfactants. Notably, the study indicated that the biosurfactant produced by mutant strain of produced more potent activities (surface tension reduction ability, high emulsification) than those of .
生物表面活性剂被应用于药物制剂中以提高药物溶解度,在某些情况下还可用于治疗疾病。本研究聚焦于从棕榈油废料和屠宰场土壤来源的细菌分离物中生成、提取、纯化并表征生物表面活性剂。从土壤和污泥样本中分离出8株细菌,其中4株(50%)被发现能产生生物表面活性剂。使用无机盐培养基、营养琼脂和溴化十六烷基三甲铵琼脂从这些样本中分离并鉴定出(37.5%)和(50%)。使用无机盐培养基作为富集培养基,利用突变株BS3和PS2来生产生物表面活性剂,并使用膜过滤器进行提取。突变株BS3和PS2产生的生物表面活性剂通过将吡罗昔康的溶解度百分比分别提高到62.86%和54.29%,显示出显著的溶解性和溶解特性,并在0.1N盐酸中实现了该药物5,171%和48.71%的溶解。从获得的结果来看,所生产的生物表面活性剂可以作为传统表面活性剂的更好替代品。值得注意的是,该研究表明,突变株产生的生物表面活性剂比产生的生物表面活性剂具有更强的活性(降低表面张力的能力、高乳化能力)。